KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in KALA BIO, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −3 vs. Q4 2024
- Shares held
- 4.14M
- +680.9K (+19.7%) vs. Q4 2024
- Total value
- $23.7M
- −$284.7K (−1.2%) vs. Q4 2024
- New holders
- 6
- 9 more added
- Sold out
- 9
- 3 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $1.21M |
| Q1 2026 | 30 | $294.0K |
| Q4 2025 | 32 | $1.58M |
| Q3 2025 | 24 | $2.69M |
| Q2 2025 | 30 | $17.3M |
| Q1 2025 | 29 | $23.7M |
| Q4 2024 | 33 | $24.0M |
| Q3 2024 | 27 | $12.1M |
| Q2 2024 | 29 | $14.8M |
| Q1 2024 | 29 | $4.88M |
| Q4 2023 | 25 | $3.68M |
| Q3 2023 | 26 | $4.57M |
| Q2 2023 | 30 | $5.56M |
| Q1 2023 | 26 | $4.81M |
| Q4 2022 | 30 | $12.8M |
| Q3 2022 | 56 | $1.36M |
| Q2 2022 | 70 | $2.27M |
| Q1 2022 | 88 | $33.7M |
| Q4 2021 | 85 | $30.9M |
| Q3 2021 | 108 | $79.5M |
| Q2 2021 | 107 | $171.3M |
| Q1 2021 | 118 | $248.9M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding KALA BIO, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 1,201,894 | $6.89M | 0.08% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 603,027 | $3.46M | 0.26% | 00.0% | Unchanged |
| Sr One Capital Management, LP | 598,940 | $3.43M | 0.88% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 298,955 | $1.71M | 0.33% | +78,582+35.7% | Added |
| Perceptive Advisors LLC | 277,610 | $1.59M | 0.06% | +277,610 | New |
| Woodline Partners LP | 258,766 | $1.48M | 0.01% | +258,766 | New |
| Silverarc Capital Management, LLC | 246,079 | $1.41M | 0.29% | +15,009+6.5% | Added |
| AIGH Capital Management LLC | 196,350 | $1.13M | 0.58% | +75,048+61.9% | Added |
| UBS Oconnor LLC | 170,917 | $979.4K | 0.02% | −8,017−4.5% | Reduced |
| Vanguard Group Inc | 152,775 | $875.4K | 0.00% | +99,205+185.2% | Added |
| Geode Capital Management, LLC | 54,833 | $314.2K | 0.00% | +7,191+15.1% | Added |
| Readystate Asset Management LP | 42,459 | $243.3K | 0.01% | +42,459 | New |
| BlackRock, Inc. | 21,356 | $122.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 10,399 | $59.6K | 0.00% | +10,399 | New |
| UBS Group AG | 3,414 | $19.6K | 0.00% | +259+8.2% | Added |
| Covestor Ltd | 1,140 | $7.00K | 0.00% | +171+17.6% | Added |
| Morgan Stanley | 972 | $5.57K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 300 | $1.72K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 221 | $1.27K | 0.00% | −491−69.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 120 | $688 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 98 | $562 | 0.00% | 00.0% | Unchanged |
| Cheviot Value Management, LLC | 153 | $555 | 0.00% | +153 | New |
| JPMorgan Chase & Co | 60 | $344 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 49 | $281 | 0.00% | +12+32.4% | Added |
| Legacy Wealth Managment, LLC | 25 | $144 | 0.00% | +15+150.0% | Added |
| Curio Wealth, LLC | 1 | $139 | 0.00% | −19−95.0% | Reduced |
| SBI Securities Co., Ltd. | 8 | $46 | 0.00% | 00.0% | Unchanged |
| Binnacle Investments Inc | 8 | $46 | 0.00% | +8 | New |
| Parallel Advisors, LLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −136,056−100.0% | Sold out |
| Board of Trustees of The Leland Stanford Junior University | 0 | $0 | 0.00% | −21,127−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −11,877−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,676−100.0% | Sold out |
| Compagnie Lombard Odier SCmA | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |